Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.39−0.03 (-0.39%)
Close on Nov 17, 2026Market cap $241.88MP/E –Yield –
Lifecore Biomedical price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lifecore Biomedical's price to book ratio was 199.3× on Oct 31, 2025, against 17.1× a year earlier. Over the last 5 years it ranged from 0.9× to 210.9×, with a median of 2.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 199.3× | +186.0 |
| 2024 | Sep 30, 2024 | 13.3× | +4.9 |
| 2023 | Jun 30, 2023 | 8.4× | +5.9 |
| 2022 | Dec 30, 2022 | 2.5× | +0.8 |
| 2021 | Dec 31, 2021 | 1.7× | +0.2 |
| 2020 | Dec 31, 2020 | 1.5× | +0.2 |
| 2019 | Dec 31, 2019 | 1.2× | −0.1 |
| 2018 | Dec 31, 2018 | 1.3× | −0.2 |
| 2017 | Dec 29, 2017 | 1.5× | −0.2 |
| 2016 | Dec 30, 2016 | 1.7× | +0.3 |
| 2015 | Dec 31, 2015 | 1.4× | −0.4 |
| 2014 | Dec 31, 2014 | 1.8× | +0.1 |
| 2013 | Dec 31, 2013 | 1.7× | +0.2 |
| 2012 | Dec 31, 2012 | 1.6× | +0.5 |
| 2011 | Dec 30, 2011 | 1.0× | – |
See a number that looks wrong?